Sidhiv Pharma(Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 917.53%
- Profit Growth 1013.56%
- Ebitda -1700.87%
- Net Worth 321.47%
- Total Assets 7.89%
About Sidhiv Pharma(Opc)
Sidhiv Pharma Private Limited (Opc) (SPPLO) is a Company incorporated in India on 03 October 2016 (Eight years and four months 9 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Venkatachala Nurani serves as a director at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999TG2016OPC112276
-
Company No.
112276
-
Incorporation Date
03 Oct 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Sidhiv Pharma Private Limited (Opc) offer?
Sidhiv Pharma Private Limited (Opc) offers a wide range of products and services, including Pharmaceutical Medicine, Pharmaceutical Products, API Intermediate, Cosmetics, Personal Care Products.
Who are the key members and board of directors at Sidhiv Pharma(Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatachala Nurani
|
Director | 03-Oct-2016 | Current |
Financial Performance of Sidhiv Pharma(Opc).
Sidhiv Pharma Private Limited (Opc), for the financial year ended 2018, experienced significant growth in revenue, with a 917.53% increase. The company also saw a substantial improvement in profitability, with a 1013.56% increase in profit. The company's net worth Soared by an impressive increase of 321.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sidhiv Pharma(Opc)?
Unlock access to Sidhiv Pharma(Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sidhiv Pharma(Opc)?
Unlock and access historical data on people associated with Sidhiv Pharma(Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sidhiv Pharma(Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sidhiv Pharma(Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.